Distinguished in ALK-Positive Non-Small Cell Lung Cancer

Dr. Christopher Lathan

Oncology
Brigham and Women’s Hospital
Dana-Farber Cancer Institute, Lowe Center For Thoracic Oncology
450 Brookline Avenue, 
Boston, MA 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Distinguished in ALK-Positive Non-Small Cell Lung Cancer
Brigham and Women’s Hospital
Dana-Farber Cancer Institute, Lowe Center For Thoracic Oncology
450 Brookline Avenue, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Christopher Lathan is an Oncologist in Boston, Massachusetts. Dr. Lathan is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.

His clinical research consists of co-authoring 75 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Tufts University School Of Medicine, 1998
Residency
Boston Medical Center, 2001
Specialties
Oncology
Licenses
Internal Medicine in MA
Board Certifications
Medical Oncology
Fellowships
Dana-Farber/Partners CancerCare, 2005
Hospital Affiliations
Boston Medical Center-Brighton
Brigham And Women's Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Dana-Farber Cancer Institute, Lowe Center for Thoracic Oncology
450 Brookline Avenue, Boston, MA 02115
Call: 617-632-6634

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)
Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)
Enrollment Status: Recruiting
Publish Date: February 12, 2026
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Carboplatin, Cisplatin, Gemcitabine Hydrochloride, Paclitaxel, Pembrolizumab, Pemetrexed Disodium
Study Phase: Phase 3
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Enrollment Status: Active_not_recruiting
Publish Date: December 03, 2025
Intervention Type: Other, Drug, Radiation, Procedure
Study Drugs: Atezolizumab, Carboplatin, Cisplatin, Etoposide
Study Phase: Phase 3
SHARE (Sharing Goals and Preferences) Study
SHARE (Sharing Goals and Preferences) Study
Enrollment Status: Completed
Publish Date: March 17, 2022
Intervention Type: Other
Study Phase: Not Applicable
View 2 Less Clinical Trial

75 Total Publications

Biomarker Testing for Non-Small Cell Lung Cancer in Community Practices Operated by an Academic Cancer Center.
Biomarker Testing for Non-Small Cell Lung Cancer in Community Practices Operated by an Academic Cancer Center.
Journal: JCO oncology practice
Published: November 10, 2025
View All 75 Publications
Similar Doctors
Distinguished in ALK-Positive Non-Small Cell Lung Cancer
Dr. Michael S. Rabin
Oncology
Distinguished in ALK-Positive Non-Small Cell Lung Cancer
Dr. Michael S. Rabin
Oncology

Dana-Farber Cancer Institute, Lowe Center For Thoracic Oncology

450 Brookline Avenue, 
Boston, MA 
 (0.1 miles away)
617-632-6049
Languages Spoken:
English
See accepted insurances

Michael Rabin is an Oncologist in Boston, Massachusetts. Dr. Rabin is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.

Distinguished in ALK-Positive Non-Small Cell Lung Cancer
Dr. Jennifer S. Temel
Oncology
Distinguished in ALK-Positive Non-Small Cell Lung Cancer
Dr. Jennifer S. Temel
Oncology

Massachusetts General Physicians Organization Inc

55 Fruit St, 
Boston, MA 
 (2.7 miles away)
617-724-0287
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jennifer Temel is an Oncologist in Boston, Massachusetts. Dr. Temel is rated as an Elite provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Bone Marrow Transplant, and Gastrostomy.

Deepa Rangachari
Distinguished in ALK-Positive Non-Small Cell Lung Cancer
Dr. Deepa Rangachari
Internal Medicine | Oncology
Distinguished in ALK-Positive Non-Small Cell Lung Cancer
Dr. Deepa Rangachari
Internal Medicine | Oncology

Beth Israel Deaconess Medical Center - Hematology/Oncology

330 Brookline Avenue, Shapiro 9, 
Boston, MA 
 (0.2 miles away)
617-667-2174
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Deepa Rangachari is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Rangachari is rated as an Elite provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Lung Cancer, EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Thymectomy.

VIEW MORE ALK-POSITIVE NON-SMALL CELL LUNG CANCER DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lathan's expertise for a condition
ConditionClose
    • Distinguished
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Lathan is
      Distinguished
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • EGFR Positive Lung Cancer
      Dr. Lathan is
      Distinguished
      . Learn about EGFR Positive Lung Cancer.
      See more EGFR Positive Lung Cancer experts
    • Large-Cell Lung Carcinoma
      Dr. Lathan is
      Distinguished
      . Learn about Large-Cell Lung Carcinoma.
      See more Large-Cell Lung Carcinoma experts
    • Lung Adenocarcinoma
      Dr. Lathan is
      Distinguished
      . Learn about Lung Adenocarcinoma.
      See more Lung Adenocarcinoma experts
    • Lung Cancer
      Dr. Lathan is
      Distinguished
      . Learn about Lung Cancer.
      See more Lung Cancer experts
    • Non-Small Cell Lung Cancer (NSCLC)
      Dr. Lathan is
      Distinguished
      . Learn about Non-Small Cell Lung Cancer (NSCLC).
      See more Non-Small Cell Lung Cancer (NSCLC) experts
    View All 9 Distinguished Conditions
    • Advanced
    • Anal Cancer
      Dr. Lathan is
      Advanced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Colorectal Cancer
      Dr. Lathan is
      Advanced
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    • Familial Colorectal Cancer
      Dr. Lathan is
      Advanced
      . Learn about Familial Colorectal Cancer.
      See more Familial Colorectal Cancer experts
    • Mesothelioma
      Dr. Lathan is
      Advanced
      . Learn about Mesothelioma.
      See more Mesothelioma experts
    • Experienced
    • Acute Myeloid Leukemia (AML)
      Dr. Lathan is
      Experienced
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • Glomus Jugulare Tumor
      Dr. Lathan is
      Experienced
      . Learn about Glomus Jugulare Tumor.
      See more Glomus Jugulare Tumor experts
    • Glomus Tympanum Tumor
      Dr. Lathan is
      Experienced
      . Learn about Glomus Tympanum Tumor.
      See more Glomus Tympanum Tumor experts
    • Leukemia
      Dr. Lathan is
      Experienced
      . Learn about Leukemia.
      See more Leukemia experts
    • Lung Nodules
      Dr. Lathan is
      Experienced
      . Learn about Lung Nodules.
      See more Lung Nodules experts
    • Lynch Syndrome
      Dr. Lathan is
      Experienced
      . Learn about Lynch Syndrome.
      See more Lynch Syndrome experts
    View All 15 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.